About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD9.20
- USD9.74
- USD9.15
- USD14.44
- -15.10%
- --
- 882.95k
- 1.07M
- 819M
- 4.93
- 61.50%
Stock News
5 hours ago
3 Super-Reliable Real Estate Stocks to Buy and Hold for Passive Income
Yahoo
6 hours ago
The 10 private colleges with the best ROI in the U.S.
CNBC
6 hours ago
Powerball jackpot nears $1 billion—here’s the after-tax payout in every U.S. state
CNBC
7 hours ago
Nvidia has $57 billion in cash. Wall Street has ideas about what to do with it.
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
